What is Ultherapy?
Ultherapy operates at the intersection of medical technology and cosmetic dermatology, providing a sophisticated, non-invasive platform for skin lifting. Utilizing advanced micro-focused ultrasound energy, the company's technology enables practitioners to visualize tissue layers in real-time, facilitating precise collagen production stimulation. This personalized approach to skin tightening has garnered a 95% patient satisfaction rate, positioning the brand as a premier choice for individuals targeting the neck, brow, and submental regions. As a market-leading entity, Ultherapy distinguishes itself through rigorous clinical validation and a commitment to safety, effectively bridging the gap between surgical intervention and topical skincare.
How much funding has Ultherapy raised?
Ultherapy has raised a total of $38.5M across 3 funding rounds:
Series B
$22.5M
Series C
$10.5M
Series A
$5.5M
Series B (2008): $22.5M with participation from 3i Group and New Enterprise Associates
Series C (2011): $10.5M led by Apposite Capital and New Enterprise Associates
Series A (2020): $5.5M supported by 3i
Key Investors in Ultherapy
3i Group
A multinational private equity and venture capital firm with a strong focus on mid-market growth and international expansion across various sectors.
New Enterprise Associates
A prominent global venture capital firm specializing in early-stage and growth-stage investments within the healthcare and technology industries.
Apposite Capital
A specialized private equity firm focused exclusively on the healthcare sector, providing strategic support to companies driving innovation in medical services and technology.
What's next for Ultherapy?
With the recent influx of capital, Ultherapy is well-positioned to accelerate its market penetration and expand its clinical footprint. The strategic focus will likely center on scaling its global distribution networks and investing in next-generation imaging technology to further enhance treatment efficacy. By maintaining its commitment to evidence-based aesthetic medicine, the company is poised to capitalize on the growing consumer demand for minimally invasive, high-performance cosmetic solutions. Future growth will be driven by continued innovation in ultrasound delivery systems and the expansion of its provider network, ensuring that Ultherapy remains at the forefront of the nonsurgical rejuvenation industry.
See full Ultherapy company page
